S Mirrett
About
S Mirrett is a scholar working on Clinical Biochemistry, Epidemiology and Public Health, Environmental and Occupational Health.
According to data from OpenAlex, S Mirrett has authored 85 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Clinical Biochemistry, 33 papers in Epidemiology and 27 papers in Public Health, Environmental and Occupational Health. Recurrent topics in S Mirrett's work include Bacterial Identification and Susceptibility Testing (64 papers), Streptococcal Infections and Treatments (25 papers) and Meta-analysis and systematic reviews (15 papers). S Mirrett is often cited by papers focused on Bacterial Identification and Susceptibility Testing (64 papers), Streptococcal Infections and Treatments (25 papers) and Meta-analysis and systematic reviews (15 papers). S Mirrett collaborates with scholars based in United States, Canada and India. S Mirrett's co-authors include L. Barth Reller, Melvin P. Weinstein, L G Reimer, Michael L. Wilson, Michael Towns, Giovanni Parmigiani, Andrew Lee, Brian A. Lauer, David R. Murdoch and James H. Tenney and has published in prestigious journals such as Clinical Infectious Diseases, The American Journal of Medicine and Journal of Clinical Microbiology.
In The Last Decade
S Mirrett
84 papers receiving 4.0k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| S Mirrett United States | 34 | 2.6k | 2.1k | 1.4k | 1.1k | 365 | 85 | 4.3k | ||
| L G Reimer United States | 24 | 1.6k 0.6× | 1.4k 0.6× | 963 0.7× | 859 0.8× | 199 0.5× | 62 | 3.2k | ||
| Richard B. Thomson United States | 33 | 1.5k 0.6× | 1.8k 0.8× | 1.0k 0.7× | 1.8k 1.7× | 169 0.5× | 94 | 4.6k | ||
| Guy Prod’hom Switzerland | 33 | 2.1k 0.8× | 2.0k 0.9× | 812 0.6× | 1.1k 1.1× | 172 0.5× | 94 | 4.6k | ||
| Phyllis Della‐Latta United States | 46 | 732 0.3× | 1.8k 0.9× | 936 0.7× | 2.4k 2.3× | 198 0.5× | 119 | 5.2k | ||
| Chatrchai Watanakunakorn United States | 35 | 991 0.4× | 1.7k 0.8× | 721 0.5× | 1.8k 1.7× | 68 0.2× | 117 | 4.3k | ||
| Peter H. Gilligan United States | 47 | 1.0k 0.4× | 4.0k 1.9× | 790 0.6× | 3.5k 3.3× | 184 0.5× | 132 | 8.5k | ||
| Silvio Pitlik Israel | 36 | 512 0.2× | 1.5k 0.7× | 1.3k 0.9× | 2.0k 1.8× | 66 0.2× | 153 | 4.6k | ||
| Tony M. Korman Australia | 36 | 961 0.4× | 2.2k 1.0× | 596 0.4× | 2.6k 2.5× | 84 0.2× | 157 | 5.1k | ||
| Mary‐Claire Roghmann United States | 36 | 1.0k 0.4× | 1.2k 0.6× | 546 0.4× | 2.2k 2.1× | 115 0.3× | 102 | 3.8k | ||
| Kenneth H. Rand United States | 38 | 681 0.3× | 2.0k 0.9× | 387 0.3× | 1.5k 1.4× | 145 0.4× | 122 | 4.7k |
Countries citing papers authored by S Mirrett
Since
Specialization
Citations
This map shows the geographic impact of S Mirrett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Mirrett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Mirrett more than expected).
Fields of papers citing papers by S Mirrett
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by S Mirrett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Mirrett. The network helps show where S Mirrett may publish in the future.
Co-authorship network of co-authors of S Mirrett
This figure shows the co-authorship network connecting the top 25 collaborators of S Mirrett. A scholar is included among the top collaborators of S Mirrett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Mirrett. S Mirrett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Doern, Christopher D., et al.. (2014). Controlled Clinical Comparison of New Pediatric Medium with Adsorbent Polymeric Beads (PF Plus) versus Charcoal-Containing PF Medium in the BacT/Alert Blood Culture System. Journal of Clinical Microbiology. 52(6). 1898–1900.
2.
Kirn, Thomas J., S Mirrett, L. Barth Reller, & Melvin P. Weinstein. (2013). Controlled Clinical Comparison of BacT/Alert FA Plus and FN Plus Blood Culture Media with BacT/Alert FA and FN Blood Culture Media. Journal of Clinical Microbiology. 52(3). 839–843.
3.
Pien, Brian C., Sylvia F. Costa, S Mirrett, et al.. (2010). The Clinical and Prognostic Importance of Positive Blood Cultures in Adults. The American Journal of Medicine. 123(9). 819–828.
4.
Simmon, Keith E., S Mirrett, L. Barth Reller, & Cathy A. Petti. (2008). Genotypic Diversity of Anaerobic Isolates from Bloodstream Infections. Journal of Clinical Microbiology. 46(5). 1596–1601.
5.
Mirrett, S, et al.. (2004). Controlled Clinical Comparison of the BacT/ALERT FN and the Standard Anaerobic SN Blood Culture Medium. Journal of Clinical Microbiology. 42(10). 4581–4585.
6.
Wilson, Michael L., et al.. (2001). Controlled Clinical Comparison of BACTEC Plus Anaerobic/F to Standard Anaerobic/F as the Anaerobic Companion Bottle to Plus Aerobic/F Medium for Culturing Blood from Adults. Journal of Clinical Microbiology. 39(3). 983–989.
7.
Kloos, Wesley E., Carol G. George, Barbara Zimmer, et al.. (1998). Staphylococcus hominis subsp. novobiosepticus subsp. nov., a novel trehalose- and N-acetyl-D-glucosamine-negative, novobiocin- and multiple-antibiotic-resistant subspecies isolated from human blood cultures. International Journal of Systematic Bacteriology. 48(3). 799–812.
8.
Weinstein, Melvin P., Michael Towns, S Mirrett, et al.. (1997). The Clinical Significance of Positive Blood Cultures in the 1990s: A Prospective Comprehensive Evaluation of the Microbiology, Epidemiology, and Outcome of Bacteremia and Fungemia in Adults. Clinical Infectious Diseases. 24(4). 584–602.
9.
McDonald, L. Clifford, Luca Gaido, Melvin P. Weinstein, et al.. (1996). Clinical importance of increased sensitivity of BacT/Alert FAN aerobic and anaerobic blood culture bottles. Journal of Clinical Microbiology. 34(9). 2180–2184.
10.
Zaidi, Anita, et al.. (1995). Value of routine anaerobic blood cultures for pediatric patients. The Journal of Pediatrics. 127(2). 263–268.
11.
Morris, Arthur J., Stephen J. Wilson, Brian P. Marx, et al.. (1995). Clinical impact of bacteria and fungi recovered only from broth cultures. Journal of Clinical Microbiology. 33(1). 161–165.
12.
Wilson, Michael L., Melvin P. Weinstein, S Mirrett, et al.. (1995). Controlled evaluation of BacT/alert standard anaerobic and FAN anaerobic blood culture bottles for the detection of bacteremia and fungemia. Journal of Clinical Microbiology. 33(9). 2265–2270.
13.
Harrell, Lizzie J., S Mirrett, & L. Barth Reller. (1994). Subcultures of Bactec-positive but Gram or acridine orange stain-negative NR 6A and 7A blood culture bottles are unnecessary. Diagnostic Microbiology and Infectious Disease. 20(3). 121–125.
14.
Wilson, Michael L. & S Mirrett. (1994). Recovery of Select Rare and Fastidious Microorganisms from Blood Cultures. Clinics in Laboratory Medicine. 14(1). 119–131.
15.
Mirrett, S. (1994). Antimicrobial Susceptibility Testing and Blood Cultures. Clinics in Laboratory Medicine. 14(1). 171–179.
16.
Wilson, Michael L., S Mirrett, L. Barth Reller, Melvin P. Weinstein, & L G Reimer. (1993). Recovery of clinically important microorganisms from the BacT/Alert blood culture system does not require testing for seven days. Diagnostic Microbiology and Infectious Disease. 16(1). 31–34.
17.
Reimer, L G, et al.. (1988). Evaluation of modified trypticase soy broth versus supplemented peptone broth in the detection of bacteremia and fungemia. European Journal of Clinical Microbiology & Infectious Diseases. 7(3). 384–387.
18.
Tenney, James H., et al.. (1982). Controlled evaluation of the volume of blood cultured in detection of bacteremia and fungemia. Journal of Clinical Microbiology. 15(4). 558–561.
19.
Mirrett, S, L. Barth Reller, & J S Knapp. (1981). Neisseria gonorrhoeae strains inhibited by vancomycin in selective media and correlation with auxotype. Journal of Clinical Microbiology. 14(1). 94–99.
20.
Reller, L. Barth & S Mirrett. (1975). Motility-indole-lysine medium for presumptive identification of enteric pathogens of Enterobacteriaceae. Journal of Clinical Microbiology. 2(3). 247–252.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by L G Reimer Breakdown of academic impact, for papers by Richard B. Thomson Breakdown of academic impact, for papers by Guy Prod’hom Breakdown of academic impact, for papers by Phyllis Della‐Latta Breakdown of academic impact, for papers by Chatrchai Watanakunakorn Breakdown of academic impact, for papers by Peter H. Gilligan Breakdown of academic impact, for papers by Silvio Pitlik Breakdown of academic impact, for papers by Tony M. Korman Breakdown of academic impact, for papers by Mary‐Claire Roghmann Breakdown of academic impact, for papers by Kenneth H. Rand